Insulet | 流动负债

股票价格
241.84
每天变化
-3.61 -1.47%
每月一次
-3.74%
每年
-10.33%
Q1 预测
239.06


金融业
股票价格
USD
资产
USD 3.19B
现金及等价物
USD 716.1M
销售成本
USD 215.2M
流动资产
USD 1.91B
流动负债
USD 680.1M
债务
USD 1.01B
EBIT
USD 146.3M
EBITDA
USD 194M
员工
3.9K
EPS每股收益
USD 1.44
股本和储备
USD 1.52B
销售毛利
USD 568.6M
债务利息支出
USD 9.2M
利息收入
USD 8.6M
贷款资金
USD 930.8M
市值
USD 16.54B
净收入
USD 101.6M
营业费用
USD 637.5M
营业利润
USD 146.3M
普通股股本
USD 70.35M
PE价格收益
USD 55.08
税前利润
USD 140.2M
销售收入
USD 783.8M
销售和管理费用
USD 331.4M
股票
USD 452.6M
贸易债权人
USD 75M
应收帐款人
USD 516.9M


流动负债 更改 日
Abbott USD 16.5B 1.91B 2025-12
Align Technology USD 1.92B 46.45M 2025-12
AtriCure USD 81.52M 3.68M 2025-12
Avanos Medical USD 165.2M 17.3M 2025-12
Baxter International USD 2.97B 805M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Cardinal Health USD 43.31B 3.05B 2025-12
Cooper Companies USD 1.11B 102.7M 2025-09
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.59B 183.3M 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Globus Medical USD 498.5M 32.54M 2025-12
ICU Medical USD 498.86M 5.96M 2025-12
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
J&J USD 54.13B 3.26B 2025-12
Masimo USD 371.6M 1.9M 2025-12
Medtronic USD 9.94B 1.6B 2025-09
Merit Medical Systems USD 239.76M 9.29M 2025-12
Roche Holding CHF 28B 421M 2025-12
Solventum Corp USD 3.14B 198M 2025-12
Stryker USD 7.79B 380M 2025-12
Tandem Diabetes Care USD 242.72M 9.82M 2025-12
Teleflex USD 762.03M 11.01M 2025-12
West Pharmaceutical Services USD 654.9M 19.5M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12


Insulet 流动负债 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.